| Literature DB >> 30020500 |
Zhuoheng Zhong1, Wei Zhu1, Shengzhi Liu1, Qijie Guan1, Xi Chen1, Wei Huang1, Tantan Wang1, Bingxian Yang1, Jingkui Tian1,2.
Abstract
Pharmaceutically active compounds from medical plants are attractive as a major source for new drug development. Prenylated stilbenoids with increased lipophilicity are valuable secondary metabolites which possess a wide range of biological activities. So far, many prenylated stilbenoids have been isolated from Morus alba but the enzyme responsible for the crucial prenyl modification remains unknown. In the present study, a stilbenoid-specific prenyltransferase (PT), termed Morus alba oxyresveratrol geranyltransferase (MaOGT), was identified and functionally characterized in vitro. MaOGT recognized oxyresveratrol and geranyl diphosphate (GPP) as natural substrates, and catalyzed oxyresveratrol prenylation. Our results indicated that MaOGT shared common features with other aromatic PTs, e.g. multiple transmembrane regions, conserved functional domains and targeting to plant plastids. This distinct PT represents the first stilbenoid-specific PT accepting GPP as a natural prenyl donor, and could help identify additional functionally varied PTs in moraceous plants. Furthermore, MaOGT might be applied for high-efficiency and large-scale prenylation of oxyresveratrol to produce bioactive compounds for potential therapeutic applications.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30020500 DOI: 10.1093/pcp/pcy138
Source DB: PubMed Journal: Plant Cell Physiol ISSN: 0032-0781 Impact factor: 4.927